Anilides
Aobchem 1-Bromo-4-(difluoromethoxy)naphthalene | ≥97% | CAS 1261783-62-3 | C11H7BrF2O | 1g
1-Bromo-4-(difluoromethoxy)naphthalene | ≥97% | CAS 1261783-62-3 | C11H7BrF2O | 1g
Medchemexpress LLC Leflunomide | 75706-12-6 | 99.8% | C12H9F3N2O2 | 1 ML
Leflunomide is a pyrimidine synthesis inhibitor that acts by inhibiting dihydroorotate dehydrogenase (DHODH), functioning as a disease-modifying antirheumatic agent. It is an immunomodulatory drug that prevents the expansion of activated and autoimmune lymphocytes by interfering with cell cycle progression due to inadequate rUMP production and by utilizing mechanisms involving p53. This product is for research use only.
- Inhibits dihydroorotate dehydrogenase (DHODH)
- Functions as a disease-modifying antirheumatic agent
- Inhibits proliferation of mononuclear and T-cells
- Inhibits several protein tyrosine kinases
- Prevents expansion of activated and autoimmune lymphocytes
![Medchemexpress LLC N-[2-methyl-3-[[4-[4-[[4-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]-1,3,5-triazin-2-yl]amino]phenyl]... | 1211866-85-1 | MFCD22123242 | 99.7% | 516.52 g/mol | C25H27F3N6O3 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000239841.png-250.jpg)
Medchemexpress LLC N-[2-methyl-3-[[4-[4-[[4-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]-1,3,5-triazin-2-yl]amino]phenyl]... | 1211866-85-1 | MFCD22123242 | 99.7% | 516.52 g/mol | C25H27F3N6O3 | 5 MG
Potent, orally active Nav1.7 sodium channel inhibitor intended for research use in ion-channel pharmacology and analgesia studies. The compound is a well-characterized small molecule with high reported purity and documented activity across human and rodent NaV subtypes; supplied in solid and solution formats with recommended cold storage.
Cambridge Isotope Laboratories Resveratrol (4-hydroxyphenyl-13C6 99%) 1 mg
Resveratrol (4-hydroxyphenyl-13C6 99%) 1 mg
Medchemexpress LLC Leflunomide | 75706-12-6 | C12H9F3N2O2 | 500 MG
Leflunomide is a pyrimidine synthesis inhibitor, primarily functioning by inhibiting dihydroorotate dehydrogenase (DHODH), and is recognized as a disease-modifying antirheumatic agent. This prodrug inhibits the proliferation of mononuclear and T-cells and acts as an inhibitor of several protein tyrosine kinases, with IC50 values ranging from 30 mM to 100 mM in in vitro assays. It also interferes with cell cycle progression and utilizes p53-dependent mechanisms to prevent the expansion of activated and autoimmune lymphocytes.
- Inhibits dihydroorotate dehydrogenase (DHODH)
- Acts as a disease-modifying antirheumatic agent
- Inhibits proliferation of mononuclear and T-cells
- Functions as an inhibitor of several protein tyrosine kinases
- Inhibits p59fyn and p56lck activity in tyrosine kinase assays
- Inhibits calcium mobilization in Jurkat cells
- Prevents expansion of activated and autoimmune lymphocytes
Apexbio Technology LLC S-Nitroso-N-acetyl-DL-penicillamine 67776-06-1 50mg
S-Nitroso-N-acetyl-DL-penicillamine (SNAP CAS 67776-06-1) is a low-molecular-weight nitric oxide (NO) donor that facilitates the sustained release of NO in biological systems By elevating NO levels SNAP stimulates soluble guanylate cyclase activity resulting in increased cyclic guanosine monophosphate (cGMP) production and subsequent modulation of downstream signaling pathways These actions contribute to vascular smooth muscle relaxation and vasodilation SNAP is widely employed in experimental studies to investigate NO-mediated mechanisms including inhibition of platelet aggregation and regulation of inflammatory responses and serves as a valuable reagent for probing NO signaling in cultured cells
![Medchemexpress LLC 2-chloro-N-(4'-chloro[1,1'-biphenyl]-2-yl)-3-pyridinecarboxamide | 188425-85-6 | 99.8% | 500 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000233956.png-250.jpg)
Medchemexpress LLC 2-chloro-N-(4'-chloro[1,1'-biphenyl]-2-yl)-3-pyridinecarboxamide | 188425-85-6 | 99.8% | 500 MG
Boscalid is a broad-spectrum carboxamide fungicide and succinate dehydrogenase (SDH) inhibitor supplied as a solid analytical standard for research and analytical applications. Typical pack contains 500 MG with a listed purity of 99.8%.
- High purity of 99.8% suitable for analytical use.
- Formula C18H12Cl2N2O with molecular weight 343.21 g·mol⁻¹.
- Solid powder appearance for easy handling and formulation.
- Storage: powder stable at -20°C (up to 3 years) or 4°C (up to 2 years); in solvent store at -80°C (6 months) or -20°C (1 month).
- Mode of action: succinate dehydrogenase (SDH) inhibitor useful in fungal respiration studies.
- Intended for research and analytical applications; not for human or veterinary use.